Tarsus Pharmaceuticals, Inc. short interest in 2021
In 2021, Tarsus Pharmaceuticals, Inc.'s disclosed short interest ran from 1.25% of shares outstanding on 15 Jan 2021 to 1.57% on 31 Dec 2021, a change of +0.32 percentage points. The year's high was 1.98% on 31 Mar 2021 and its low 1.25% on 15 Jan 2021, averaging 1.61% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.77 days on 30 Sep 2021. Full history: Tarsus Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 1.25% (15 Jan 2021)
- End of year
- 1.57% (31 Dec 2021)
- Change
- +0.32 pp
- High
- 1.98% (31 Mar 2021)
- Low
- 1.25% (15 Jan 2021)
- Average
- 1.61%
- Highest days to cover
- 23.77 (30 Sep 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 1.25% | 3.77 | |
| 29 Jan 2021 | 1.28% | 8.82 | |
| 12 Feb 2021 | 1.72% | 17.15 | |
| 26 Feb 2021 | 1.82% | 8.37 | |
| 15 Mar 2021 | 1.94% | 15.23 | |
| 31 Mar 2021 | 1.98% | 12.37 | 10-K filed, results (8-K) |
| 15 Apr 2021 | 1.87% | 11.41 | |
| 30 Apr 2021 | 1.87% | 10.10 | |
| 14 May 2021 | 1.81% | 5.03 | 10-Q filed, results (8-K) |
| 28 May 2021 | 1.53% | 5.53 | |
| 15 Jun 2021 | 1.37% | 5.21 | |
| 30 Jun 2021 | 1.55% | 1.94 | |
| 15 Jul 2021 | 1.60% | 12.15 | |
| 30 Jul 2021 | 1.55% | 9.04 | |
| 13 Aug 2021 | 1.51% | 9.20 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 1.48% | 11.07 | |
| 15 Sep 2021 | 1.60% | 11.33 | |
| 30 Sep 2021 | 1.60% | 23.77 | |
| 15 Oct 2021 | 1.61% | 7.89 | |
| 29 Oct 2021 | 1.57% | 12.33 | |
| 15 Nov 2021 | 1.51% | 6.65 | results (8-K), 10-Q filed |
| 30 Nov 2021 | 1.53% | 12.46 | |
| 15 Dec 2021 | 1.57% | 15.95 | |
| 31 Dec 2021 | 1.57% | 15.00 |
See also: Tarsus Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.